AP NEWS

CLASS ACTION UPDATE for DBVT, MKL, VALE and TYME: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

February 7, 2019

NEW YORK, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

DBV Technologies S.A. (NASDAQ: DBVT) Class Period: February 14, 2018 - December 19, 2018 Lead Plaintiff Deadline: March 18, 2019 Join the action: https://www.zlk.com/pslra-1/dbv-technologies-s-a-loss-form?wire=3

About the lawsuit: DBV Technologies S.A. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (1) DBV Technologies’ Biologics License Application (“BLA”) for Viaskin Peanut failed to provide the FDA with sufficient data on manufacturing procedures and quality controls; (2) consequently, DBV Technologies voluntarily withdrew the BLA for Viaskin Peanut; and (3) as a result, defendants’ statements about DBV Technologies’ business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the DBV Technologies S.A. class action contact jlevi@levikorsinsky.com.

Markel Corporation (NYSE: MKL) Class Period: July 26, 2017 - December 6, 2018 Lead Plaintiff Deadline: March 12, 2019 Join the action: https://www.zlk.com/pslra-1/markel-corporation-loss-form?wire=3

About the lawsuit: Throughout the class period, Markel Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s subsidiaries did not appropriately record loss reserves; (2) as a result, the loss reserves would need to be adjusted and/or restated; (3) these misleading accounting practices would lead to regulatory scrutiny and financial loss to investors; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

To learn more about the Markel Corporation class action contact jlevi@levikorsinsky.com.

Vale S.A. (NYSE: VALE) Class Period: April 13, 2018 - January 28, 2019 Lead Plaintiff Deadline: March 29, 2019 Join the action: https://www.zlk.com/pslra-1/vale-s-a-loss-form?wire=3

About the lawsuit: Vale S.A. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Vale had failed to adequately assess the risk and damage potential of a dam breach at its Feijão iron ore mine; (2) Vale’s programs to mitigate health and safety incidents were inadequate; (3) consequently, several people were killed and hundreds more were reported missing after Vale’s dam at its Feijão mine was breached; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the Vale S.A. class action contact jlevi@levikorsinsky.com.

Tyme Technologies, Inc. (NASDAQCM: TYME) Class Period: March 14, 2018 - January 18, 2019 Lead Plaintiff Deadline: March 29, 2019 Join the action: https://www.zlk.com/pslra-1/tyme-technologies-inc-loss-form?wire=3

About the lawsuit: Throughout the class period, Tyme Technologies, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Tyme had not adequately designed the Phase II Study to present reliable results on the efficacy of SM-88 on pancreatic cancer; (ii) Tyme had failed to include an appropriate control group in its open-label Phase II clinical trial for SM-88; (iii) the omission of an appropriate control group distorted the reliability of data showing the efficacy of SM-88 in the Phase II Study; and (iv) as a result, Tyme’s public statements were materially false and misleading at all relevant times.

To learn more about the Tyme Technologies, Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.55 Broadway, 10th FloorNew York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com

AP RADIO
Update hourly